SUNSHINE PHARMA (06887)

Director	From	To	Position(s)	Release Date / Document Links	Reason for Change
Cheng Ching Kit	29-May-26		AuRep
Cheng Ching Kit	26-Feb-24		CoSec
Li Wenjia	19-Jan-21	29-May-26	ED, GM	29-May-26	Dr. LI Wenjia will cease to be one of the Company's authorised representatives.
Li Wenjia		29-May-26	AuRep	29-May-26	Dr. LI Wenjia will cease to be one of the Company's authorised representatives.
Zeng Xuebo	11-Dec-24	28-May-26	Non-Executive Director	28-May-26	Will not seek re-election to the second session of the Board due to change of board session and will retire.
Dong Xiaowei	15-Jul-21	28-May-26	Non-Executive Director	28-May-26	Will not seek re-election to the second session of the Board due to change of board session and will retire.
Wang Lei	10-Dec-21	28-May-26	Non-Executive Director	28-May-26	Will not seek re-election to the second session of the Board due to change of board session and will retire.
Yin Hang Hubert	10-May-24	28-May-26	INED	28-May-26	Will not seek re-election to the second session of the Board due to change of board session and will retire.